跳至主要内容
临床试验/NL-OMON20525
NL-OMON20525尚未招募不适用

Heavy menstrual bleeding in premenopausal women treated with direct oral anticoagulants - the MEDEA Study

Amsterdam University Medical Centers - location AMC0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • premenopausal women
  • -age =18 years
  • -anticoagulant treatment with a factor Xa inhibitor
  • -indication for anticoagulant treatment >3months after inclusion
  • -heavy menstrual bleeding and a PBAC-score >150
  • -use of adequate contraceptive methods during study participation (this is advised to any woman on factor Xa inhibitors during fertile ages, regardless of study participation)

排除标准

  • -PBAC-score =150
  • -Postmenopausal women; women >12 consecutive months of spontaneous amenorrhea
  • -concomitant use of hormonal therapy as a new intervention for HMB
  • -pregnancy or currently planning for pregnancy
  • -active malignancy or treatment with chemotherapy/radiotherapy
  • -cervical preneoplastic lesions
  • -contra indication for the registered products dabigatran or tranexamic acid
  • -any condition that, as judged by investigator, would place the subject at an increased risk of harm if she participated in the study

研究者

发起方
Amsterdam University Medical Centers - location AMC

相似试验